Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations

Carmine Pinto, Silvia Novello, Valter Torri, Andrea Ardizzoni, Pier Giacomo Betta, Pier Alberto Bertazzi, Gianni Angelo Casalini, Cesare Fava, Bice Fubini, Corrado Magnani, Dario Mirabelli, Mauro Papotti, Umberto Ricardi, Gaetano Rocco, Ugo Pastorino, Gianfranco Tassi, Lucio Trodella, Maurizio Zompatori, Giorgio Scagliotti

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence has considerably and constantly increased over the past two decades in industrialized countries and is expected to peak in 2010-2020. In Italy, the standardized incidence rate in 2008 was 3.6 and 1.3 per 100,000 in men and women respectively, with wide differences from one region to another. The approach to this disease remains difficult and complex in terms of pathogenic mechanism, diagnosis, staging and treatment thus an optimal strategy has not yet been clearly defined. The Second Italian Multidisciplinary Consensus Conference on Malignant Pleural Mesothelioma was held in Turin (Italy) on November 24-25, 2011: recommendations on MPM management for public health institutions, clinicians and patients are presented in this report.

Original languageEnglish
Pages (from-to)328-339
Number of pages12
JournalCancer Treatment Reviews
Volume39
Issue number4
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Italy
Public Health
Asbestos
Mesothelioma
Incidence
Developed Countries
Malignant Mesothelioma
Therapeutics

Keywords

  • Diagnosis
  • Epidemiology
  • Etiology
  • Italian recommendations
  • Malignant pleural mesothelioma
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Second Italian Consensus Conference on Malignant Pleural Mesothelioma : State of the art and recommendations. / Pinto, Carmine; Novello, Silvia; Torri, Valter; Ardizzoni, Andrea; Betta, Pier Giacomo; Bertazzi, Pier Alberto; Casalini, Gianni Angelo; Fava, Cesare; Fubini, Bice; Magnani, Corrado; Mirabelli, Dario; Papotti, Mauro; Ricardi, Umberto; Rocco, Gaetano; Pastorino, Ugo; Tassi, Gianfranco; Trodella, Lucio; Zompatori, Maurizio; Scagliotti, Giorgio.

In: Cancer Treatment Reviews, Vol. 39, No. 4, 06.2013, p. 328-339.

Research output: Contribution to journalArticle

Pinto, C, Novello, S, Torri, V, Ardizzoni, A, Betta, PG, Bertazzi, PA, Casalini, GA, Fava, C, Fubini, B, Magnani, C, Mirabelli, D, Papotti, M, Ricardi, U, Rocco, G, Pastorino, U, Tassi, G, Trodella, L, Zompatori, M & Scagliotti, G 2013, 'Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations', Cancer Treatment Reviews, vol. 39, no. 4, pp. 328-339. https://doi.org/10.1016/j.ctrv.2012.11.004
Pinto, Carmine ; Novello, Silvia ; Torri, Valter ; Ardizzoni, Andrea ; Betta, Pier Giacomo ; Bertazzi, Pier Alberto ; Casalini, Gianni Angelo ; Fava, Cesare ; Fubini, Bice ; Magnani, Corrado ; Mirabelli, Dario ; Papotti, Mauro ; Ricardi, Umberto ; Rocco, Gaetano ; Pastorino, Ugo ; Tassi, Gianfranco ; Trodella, Lucio ; Zompatori, Maurizio ; Scagliotti, Giorgio. / Second Italian Consensus Conference on Malignant Pleural Mesothelioma : State of the art and recommendations. In: Cancer Treatment Reviews. 2013 ; Vol. 39, No. 4. pp. 328-339.
@article{acf5f48fd7cb44dcb626557525aaf671,
title = "Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations",
abstract = "Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence has considerably and constantly increased over the past two decades in industrialized countries and is expected to peak in 2010-2020. In Italy, the standardized incidence rate in 2008 was 3.6 and 1.3 per 100,000 in men and women respectively, with wide differences from one region to another. The approach to this disease remains difficult and complex in terms of pathogenic mechanism, diagnosis, staging and treatment thus an optimal strategy has not yet been clearly defined. The Second Italian Multidisciplinary Consensus Conference on Malignant Pleural Mesothelioma was held in Turin (Italy) on November 24-25, 2011: recommendations on MPM management for public health institutions, clinicians and patients are presented in this report.",
keywords = "Diagnosis, Epidemiology, Etiology, Italian recommendations, Malignant pleural mesothelioma, Therapy",
author = "Carmine Pinto and Silvia Novello and Valter Torri and Andrea Ardizzoni and Betta, {Pier Giacomo} and Bertazzi, {Pier Alberto} and Casalini, {Gianni Angelo} and Cesare Fava and Bice Fubini and Corrado Magnani and Dario Mirabelli and Mauro Papotti and Umberto Ricardi and Gaetano Rocco and Ugo Pastorino and Gianfranco Tassi and Lucio Trodella and Maurizio Zompatori and Giorgio Scagliotti",
year = "2013",
month = "6",
doi = "10.1016/j.ctrv.2012.11.004",
language = "English",
volume = "39",
pages = "328--339",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Second Italian Consensus Conference on Malignant Pleural Mesothelioma

T2 - State of the art and recommendations

AU - Pinto, Carmine

AU - Novello, Silvia

AU - Torri, Valter

AU - Ardizzoni, Andrea

AU - Betta, Pier Giacomo

AU - Bertazzi, Pier Alberto

AU - Casalini, Gianni Angelo

AU - Fava, Cesare

AU - Fubini, Bice

AU - Magnani, Corrado

AU - Mirabelli, Dario

AU - Papotti, Mauro

AU - Ricardi, Umberto

AU - Rocco, Gaetano

AU - Pastorino, Ugo

AU - Tassi, Gianfranco

AU - Trodella, Lucio

AU - Zompatori, Maurizio

AU - Scagliotti, Giorgio

PY - 2013/6

Y1 - 2013/6

N2 - Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence has considerably and constantly increased over the past two decades in industrialized countries and is expected to peak in 2010-2020. In Italy, the standardized incidence rate in 2008 was 3.6 and 1.3 per 100,000 in men and women respectively, with wide differences from one region to another. The approach to this disease remains difficult and complex in terms of pathogenic mechanism, diagnosis, staging and treatment thus an optimal strategy has not yet been clearly defined. The Second Italian Multidisciplinary Consensus Conference on Malignant Pleural Mesothelioma was held in Turin (Italy) on November 24-25, 2011: recommendations on MPM management for public health institutions, clinicians and patients are presented in this report.

AB - Malignant pleural mesothelioma (MPM) is a relevant public health issue. A large amount of data indicate a relationship between mesothelioma and asbestos exposure. MPM incidence has considerably and constantly increased over the past two decades in industrialized countries and is expected to peak in 2010-2020. In Italy, the standardized incidence rate in 2008 was 3.6 and 1.3 per 100,000 in men and women respectively, with wide differences from one region to another. The approach to this disease remains difficult and complex in terms of pathogenic mechanism, diagnosis, staging and treatment thus an optimal strategy has not yet been clearly defined. The Second Italian Multidisciplinary Consensus Conference on Malignant Pleural Mesothelioma was held in Turin (Italy) on November 24-25, 2011: recommendations on MPM management for public health institutions, clinicians and patients are presented in this report.

KW - Diagnosis

KW - Epidemiology

KW - Etiology

KW - Italian recommendations

KW - Malignant pleural mesothelioma

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84875501482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875501482&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2012.11.004

DO - 10.1016/j.ctrv.2012.11.004

M3 - Article

C2 - 23244777

AN - SCOPUS:84875501482

VL - 39

SP - 328

EP - 339

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 4

ER -